Discontinued — last reported Q1 '26
EBIT at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's EBIT?
- Pacific Biosciences of California (PACB) reported EBIT of -$8.36M in Q1 2026.
- How has Pacific Biosciences of California's EBIT changed year-over-year?
- Pacific Biosciences of California's EBIT increased by 98.1% year-over-year, from -$428.93M to -$8.36M.
- What is the long-term trend for Pacific Biosciences of California's EBIT?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's EBIT has grown at a 27.4% compound annual growth rate (CAGR), from -$210.44M to -$553.86M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.